Diagnostic value of hemoglobin a1c for type 2 diabetes mellitus in a population at risk

Experimental and Clinical Endocrinology and Diabetes

Volumn 119, Issue 4, 2011, Pages 234-237

  Peter, A ^a,b   Fritsche, A ^a,b   Stefan, N ^a,b   Heni, M ^a,b   Haring H U ^a,b   Schleicher, E ^a,b  

^a GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

diagnostic criteria; HbA1c; OGTT

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GLUCOSE TOLERANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 79953269340     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0030-1270440     Document Type: Article

References (20)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010 33 62-69
2. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 20 1183-1197
3. Stefan N, Hennige AM, Staiger H et al,. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006 29 853-857 (Pubitemid 44115306)
4. International Expert Committee. report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009 32 1327-1334
5. Consensus Committee. Consensus statement on the worldwide standardization of the haemoglobin A1c measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation Diabetes. Care 2007 30 2399-2400
6. Selvin E, Steffes MW, Zhu H et al,. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010 362 800-811
7. van t Riet E, Alssema M, Rijkelijkhuizen JM et al,. Relationship between A1c and Glucose Levels in the General Dutch Population: The New Hoorn Study. Diabetes Care 2010 33 61-66
8. Cohen RM, Franco RS, Khera PK et al,. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008 112 4284-4291
9. Snieder H, Sawtell PA, Ross L et al,. HbA1c levels are genetically determined even in type 1 diabetes. Evidence from healthy and diabetic twins. Diabetes 2001 50 2858-2863 (Pubitemid 33733139)
10. Snieder H, Florez JC. A genome-wide association study of treated A1C: a genetic needle in an environmental haystack? Diabetes 2010 59 332-334
11. Little RR, Sacks DB. HbA1c: how do we measure it and what does it mean? Curr Opin Endocrinol Diabetes Obes 2009 16 113-118
12. 1c in the Diabetes Control and Complications Trial. Diabetes Care 2002 25 275-278 (Pubitemid 41079621)
13. Young IS. The Reporting of Estimated Glucose with Hemoglobin A1c. Clin Chem 2010 Apr; 54 (4) 547-549
14. Herman WH, Ma Y, Uwaifo G et al,. Diabetes Prevention Program Research Group. Differences in A1c by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007 Oct 30 10 2453-2457 (Pubitemid 47547771)
15. Singleton JR, Smith AG, Russell JW et al,. Microvascular complications of impaired glucose tolerance. Diabetes 2003 52 2867-2873 (Pubitemid 37466854)
16. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 1999 Aug 21 354 9179 617-621
17. Tominaga M, Eguchi H, Manaka H et al,. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1999 Jun 22 6 920-924 (Pubitemid 29241045)
18. Eddy D, Schlessinger L, Kahn R et al,. Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis. Diabetes Care 2009 Feb 32: 361-366
19. Cederberg H, Saukkonen T, Laakso M et al,. Postchallenge Glucose, HbA1c, and Fasting Glucose as Predictors of Type 2 Diabetes and Cardiovascular Disease: A 10-year Prospective Cohort Study. Diabetes Care 2010 Sep 33 (9) 2077-2083
20. Li-nong J, Wei L, Wei L et al,. Impact of newly recommended HbA1c-based diabetes diagnostic criteria on the prevalence of diabetes and high risk individual in clinical and community population in China. Chin Med J (Engl) 2010 Apr 20 123 8 1103-1104